These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 34791805

  • 21. Safety and efficacy of administering reduced doses of pegylated recombinant human granulocyte-colony stimulating factors in patients treated with cisplatin and etoposide for small cell carcinoma: A retrospective study.
    Liu C, Hao Y, Wang L, Meng F, Wen F, Zhong D.
    Thorac Cancer; 2021 Apr; 12(8):1154-1161. PubMed ID: 33590721
    [Abstract] [Full Text] [Related]

  • 22. [Pharmacokinetics and pharmacodynamics of pegylated recombinant human granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia: a prospective control trial].
    Yang WY, Liu TF, Chen XJ, Guo Y, Li T, Qi BQ, Liu F, Chang LX, Ruan M, Liu XM, Zhang L, Zou Y, Chen YM, Zhu XF.
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Nov; 22(11):1172-1177. PubMed ID: 33172550
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics and Pharmacodynamics of Two Formulations of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor in Healthy Chinese Subjects: An Open-Label, Randomized, Parallel-Design Bioavailability Study.
    Hu C, Ji B, Hu X, Yang C, Sun W, Zhao X, Li L, Li X, Zhang L.
    Clin Pharmacol Drug Dev; 2021 Mar; 10(3):291-298. PubMed ID: 32567217
    [Abstract] [Full Text] [Related]

  • 24. Clinical efficacy and safety of mecapegfilgrastim in small cell lung cancer as primary prophylaxis of neutropenia post chemotherapy: a retrospective analysis.
    Gu X, Zhang Y.
    Ann Palliat Med; 2021 Jul; 10(7):7841-7846. PubMed ID: 34353071
    [Abstract] [Full Text] [Related]

  • 25. Effects of Prophylactic Administration of Granulocyte Colony-Stimulating Factor on Peripheral Leukocyte and Neutrophil Counts Levels After Chemotherapy in Patients With Early-Stage Breast Cancer: A Retrospective Cohort Study.
    Tian W, Wang Y, Zhou Y, Yao Y, Deng Y.
    Front Oncol; 2022 Jul; 12():777602. PubMed ID: 35547875
    [Abstract] [Full Text] [Related]

  • 26. [A multicenter, randomized, controlled, phase Ⅳ clinical study of PEG-rhG-CSF for preventing chemotherapy induced neutropenia in patients with breast cancer].
    Jiang ZF, Xu FR, Fan J, Li BJ, Gao JN, Hu JW, Wang XJ, Zhang YQ, Wang JH, Li F, Liu Q, Liu YH, Wang S, Wang YS, Ouyang QC, Hu B, Sun GP, Zhang Y, Zang AM, Fan PZ, Wu CP, Liu J, Zhang HW, Wang W, Hu XC, Tang LL, Zhang J, Bao YY, Geng CZ, Sun Q, Zhang F, Yin YM, Jiang HC, An YH.
    Zhonghua Yi Xue Za Zhi; 2018 Apr 24; 98(16):1231-1235. PubMed ID: 29747310
    [Abstract] [Full Text] [Related]

  • 27. A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.
    Eguchi K, Etou H, Miyachi S, Morinari H, Nakada K, Noda K, Ohkuni Y, Watanabe K, Yamada Y, Ohe Y.
    Eur J Cancer; 1994 Apr 24; 30A(2):188-94. PubMed ID: 7512356
    [Abstract] [Full Text] [Related]

  • 28. Optimal schedule for administering granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in non-small-cell lung cancer.
    Soda H, Oka M, Fukuda M, Kinoshita A, Sakamoto A, Araki J, Fujino S, Itoh N, Watanabe K, Kanda T, Nakano M, Hara K.
    Cancer Chemother Pharmacol; 1996 Apr 24; 38(1):9-12. PubMed ID: 8603458
    [Abstract] [Full Text] [Related]

  • 29. [Cost-effectiveness of primary prophylaxis with PEG-rhG-CSF in early-stage breast cancer patients receiving chemotherapy in China].
    Xia W, Wang SS, Hu H, Zhao FL, Xu F, Hong RX, Jiang KK, Yuan ZY, Shi YX, Zhao K, Huang JJ, Xue C, Bi XW, Lu QY, An X, Zhang JM.
    Zhonghua Zhong Liu Za Zhi; 2020 Oct 23; 42(10):861-867. PubMed ID: 33113628
    [Abstract] [Full Text] [Related]

  • 30. [Clinical observation of the salvage therapy using pegylated recombinant human granulocyte colony stimulating factor for grade IV neutropenia induced by concurrent chemoradiotherapy].
    Wu F, Wang H, Li N, Guo Y, Cheng Y, Liu Q, Yang X, Wan X, Wang J.
    Zhonghua Zhong Liu Za Zhi; 2014 Sep 23; 36(9):708-12. PubMed ID: 25564064
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer.
    Li W, Dong M, Huang S, Shi L, Yang H, Zhang Y, Gong J, Shi M, Wei L, Zhao L.
    Biomol Biomed; 2023 Mar 16; 23(2):310-316. PubMed ID: 36300280
    [Abstract] [Full Text] [Related]

  • 32. Clinical significance of primary prophylactic pegylated-granulocyte-colony stimulating factor after the administration of ramucirumab plus docetaxel in patients with previously treated non-small cell lung cancer.
    Mouri A, Kaira K, Shiono A, Yamaguchi O, Murayama Y, Kobayashi K, Kagamu H.
    Thorac Cancer; 2019 Apr 16; 10(4):1005-1008. PubMed ID: 30859745
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics and safety of pegylated recombinant human granulocyte colony-stimulating factor in children with acute leukaemia.
    Liu XT, Zhao YX, Jia GW, Yang F, Zhang CZ, Han B, Dai JH, Han YQ, Tang BH, Yang XM, Shi HY, Zhou Y, Sui ZG, Chen JZ, van den Anker JN, Zhao W.
    Br J Clin Pharmacol; 2021 Aug 16; 87(8):3292-3300. PubMed ID: 33506975
    [Abstract] [Full Text] [Related]

  • 34. [A single-center, randomized controlled trial of PEG-rhG-CSF and common rhG-CSF to promote neutrophil recovery after induction chemotherapy in newly diagnosed acute myeloid leukemia].
    Liu KQ, Wang Y, Zhao Z, Lin D, Zhou CL, Liu BC, Gong XY, Zhao XL, Wei SN, Zhang GJ, Gong BF, Li Y, Liu YT, Mi YC, Wang JX, Wei H.
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jun 14; 40(6):497-501. PubMed ID: 31340623
    [Abstract] [Full Text] [Related]

  • 35. Is PEGylated G-CSF superior to G-CSF in patients with breast cancer receiving chemotherapy? A systematic review and meta-analysis.
    Li X, Zheng H, Yu MC, Wang W, Wu XH, Yang DM, Xu J.
    Support Care Cancer; 2020 Nov 14; 28(11):5085-5097. PubMed ID: 32621264
    [Abstract] [Full Text] [Related]

  • 36. A clinical study of polyethylene glycol recombinant human granulocyte colony-stimulating factor prevention neutropenia syndrome in patients with esophageal carcinoma and lung cancer after concurrent chemoradiotherapy.
    Liu F, Du Y, Cai B, Yan M, Yang W, Wang Q.
    J Cancer Res Ther; 2017 Nov 14; 13(5):790-795. PubMed ID: 29237905
    [Abstract] [Full Text] [Related]

  • 37. [Clinical study of recombinant human granulocyte colony-stimulating factor (RHG-CSF) on leucopenia induced by chemotherapy with CE regimen on lung cancer patients].
    Shi YK, Feng FY, Sun Y.
    Zhonghua Nei Ke Za Zhi; 1994 Nov 14; 33(11):739-42. PubMed ID: 7541325
    [Abstract] [Full Text] [Related]

  • 38. Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab: a single-center retrospective study.
    Kitagawa Y, Osumi H, Shinozaki E, Ota Y, Nakayama I, Suzuki T, Wakatsuki T, Ogura M, Ooki A, Takahari D, Suenaga M, Chin K, Yamaguchi K.
    BMC Cancer; 2020 Apr 28; 20(1):358. PubMed ID: 32345249
    [Abstract] [Full Text] [Related]

  • 39. A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia.
    Qin Y, Han X, Wang L, Du P, Yao J, Wu D, Song Y, Zhang S, Tang L, Shi Y.
    Chin J Cancer Res; 2017 Oct 28; 29(5):402-410. PubMed ID: 29142459
    [Abstract] [Full Text] [Related]

  • 40. Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II study.
    Huang J, Zhu J, Jiang L, Xu J, Lin X, Chang J, Zhang X, Lu S, Sun F, Wang J, Que Y, Ye Z, Yang L, Yuan X, Cai W, Tian C, Wu Y, He X, Tang YL, Zhang Y.
    Front Pharmacol; 2024 Oct 28; 15():1419369. PubMed ID: 39086394
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.